US Patent 10081661 Methods and compositions for genome engineering
Patent 10081661 was granted and assigned to Sangamo Therapeutics on September, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 9, 2014
Date of Patent
September 25, 2018
Patent Application Number
14565014
Patent Citations Received
Patent Inventor Names
Thomas Wechsler
0
David Paschon
0
Edward J. Rebar
0
Jeffrey C. Miller
0
Lei Zhang
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10081661 Methods and compositions for genome engineering
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
